Telomere structure and maintenance gene variants and risk of five cancer types
- PMID: 27459707
- PMCID: PMC5198774
- DOI: 10.1002/ijc.30288
Telomere structure and maintenance gene variants and risk of five cancer types
Abstract
Telomeres cap chromosome ends, protecting them from degradation, double-strand breaks, and end-to-end fusions. Telomeres are maintained by telomerase, a reverse transcriptase encoded by TERT, and an RNA template encoded by TERC. Loci in the TERT and adjoining CLPTM1L region are associated with risk of multiple cancers. We therefore investigated associations between variants in 22 telomere structure and maintenance gene regions and colorectal, breast, prostate, ovarian, and lung cancer risk. We performed subset-based meta-analyses of 204,993 directly-measured and imputed SNPs among 61,851 cancer cases and 74,457 controls of European descent. Independent associations for SNP minor alleles were identified using sequential conditional analysis (with gene-level p value cutoffs ≤3.08 × 10-5 ). Of the thirteen independent SNPs observed to be associated with cancer risk, novel findings were observed for seven loci. Across the DCLRE1B region, rs974494 and rs12144215 were inversely associated with prostate and lung cancers, and colorectal, breast, and prostate cancers, respectively. Across the TERC region, rs75316749 was positively associated with colorectal, breast, ovarian, and lung cancers. Across the DCLRE1B region, rs974404 and rs12144215 were inversely associated with prostate and lung cancers, and colorectal, breast, and prostate cancers, respectively. Near POT1, rs116895242 was inversely associated with colorectal, ovarian, and lung cancers, and RTEL1 rs34978822 was inversely associated with prostate and lung cancers. The complex association patterns in telomere-related genes across cancer types may provide insight into mechanisms through which telomere dysfunction in different tissues influences cancer risk.
Keywords: GWAS; breast cancer; cancer risk; colorectal cancer; lung cancer; meta-analysis; ovarian cancer; prostate cancer; telomere maintenance; telomere structure.
© 2016 UICC.
Conflict of interest statement
Author’s disclosures of potential conflicts of interest: non for all authors.
Figures



References
-
- Codd V, Nelson CP, Albrecht E, Mangino M, Deelen J, Buxton JL, Hottenga JJ, Fischer K, Esko T, Surakka I, Broer L, Nyholt DR, Mateo Leach I, Salo P, Hägg S, Matthews MK, Palmen J, Norata GD, O’Reilly PF, Saleheen D, Amin N, Balmforth AJ, Beekman M, de Boer RA, Böhringer S, Braund PS, Burton PR, de Craen AJ, Denniff M, Dong Y, Douroudis K, Dubinina E, Eriksson JG, Garlaschelli K, Guo D, Hartikainen AL, Henders AK, Houwing-Duistermaat JJ, Kananen L, Karssen LC, Kettunen J, Klopp N, Lagou V, van Leeuwen EM, Madden PA, Mägi R, Magnusson PK, Männistö S, McCarthy MI, Medland SE, Mihailov E, Montgomery GW, Oostra BA, Palotie A, Peters A, Pollard H, Pouta A, Prokopenko I, Ripatti S, Salomaa V, Suchiman HE, Valdes AM, Verweij N, Viñuela A, Wang X, Wichmann HE, Widen E, Willemsen G, Wright MJ, Xia K, Xiao X, van Veldhuisen DJ, Catapano AL, Tobin MD, Hall AS, Blakemore AI, van Gilst WH, Zhu H, Erdmann J, Reilly MP, Kathiresan S, Schunkert H, Talmud PJ, Pedersen NL, Perola M, Ouwehand W, Kaprio J, Martin NG, van Duijn CM, Hovatta I, Gieger C, Metspalu A, Boomsma DI, Jarvelin MR, Slagboom PE, Thompson JR, Spector TD, van der Harst P, Samani NJ Consortium C. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet. 2013;45:422–427. - PMC - PubMed
-
- Levy D, Neuhausen SL, Hunt SC, Kimura M, Hwang SJ, Chen W, Bis JC, Fitzpatrick AL, Smith E, Johnson AD, Gardner JP, Srinivasan SR, Schork N, Rotter JI, Herbig U, Psaty BM, Sastrasinh M, Murray SS, Vasan RS, Province MA, Glazer NL, Lu X, Cao X, Kronmal R, Mangino M, Soranzo N, Spector TD, Berenson GS, Aviv A. Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology. Proc Natl Acad Sci U S A. 2010;107:9293–9298. - PMC - PubMed
-
- Mangino M, Brouilette S, Braund P, Tirmizi N, Vasa-Nicotera M, Thompson JR, Samani NJ. A regulatory SNP of the BICD1 gene contributes to telomere length variation in humans. Hum Mol Genet. 2008;17:2518–2523. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 CA087969/CA/NCI NIH HHS/United States
- HHSN268201100046C/HL/NHLBI NIH HHS/United States
- HHSN268201100003C/WH/WHI NIH HHS/United States
- U01 CA164930/CA/NCI NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- HHSN271201100004C/AG/NIA NIH HHS/United States
- R01 CA060987/CA/NCI NIH HHS/United States
- UM1 CA167551/CA/NCI NIH HHS/United States
- P50 CA127003/CA/NCI NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
- R01 CA059045/CA/NCI NIH HHS/United States
- HHSN268201100001I/HL/NHLBI NIH HHS/United States
- U19 CA148127/CA/NCI NIH HHS/United States
- R01 CA076366/CA/NCI NIH HHS/United States
- R35 CA197449/CA/NCI NIH HHS/United States
- U01 HG004438/HG/NHGRI NIH HHS/United States
- 17528/CRUK_/Cancer Research UK/United Kingdom
- U01 HG004446/HG/NHGRI NIH HHS/United States
- P50 CA180995/CA/NCI NIH HHS/United States
- HHSN268201100004I/HL/NHLBI NIH HHS/United States
- Z01 CP010200/ImNIH/Intramural NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- K05 CA154337/CA/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- R01 CA151993/CA/NCI NIH HHS/United States
- R01 CA048998/CA/NCI NIH HHS/United States
- U01 CA137088/CA/NCI NIH HHS/United States
- P30 CA023108/CA/NCI NIH HHS/United States
- R01 CA137178/CA/NCI NIH HHS/United States
- R01 CA128978/CA/NCI NIH HHS/United States
- R01 ES020506/ES/NIEHS NIH HHS/United States
- K07 CA160753/CA/NCI NIH HHS/United States
- P30 CA014089/CA/NCI NIH HHS/United States
- U19 CA148537/CA/NCI NIH HHS/United States
- R01 CA081488/CA/NCI NIH HHS/United States
- R01 CA063464/CA/NCI NIH HHS/United States
- P01 CA033619/CA/NCI NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- HHSN268201100002C/WH/WHI NIH HHS/United States
- R01 CA122443/CA/NCI NIH HHS/United States
- P30 CA015083/CA/NCI NIH HHS/United States
- 15007/CRUK_/Cancer Research UK/United Kingdom
- R01 CA042182/CA/NCI NIH HHS/United States
- R01 CA054281/CA/NCI NIH HHS/United States
- U19 CA148112/CA/NCI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- U19 CA148065/CA/NCI NIH HHS/United States
- S10 OD020069/OD/NIH HHS/United States
- 10119/CRUK_/Cancer Research UK/United Kingdom
- HHSN268201100003I/HL/NHLBI NIH HHS/United States
- HHSN268201100002I/HL/NHLBI NIH HHS/United States
- U01 CA074783/CA/NCI NIH HHS/United States
- R01 CA151989/CA/NCI NIH HHS/United States
- 001/WHO_/World Health Organization/International
- U01 CA164973/CA/NCI NIH HHS/United States
- R37 CA054281/CA/NCI NIH HHS/United States
- P50 CA136393/CA/NCI NIH HHS/United States
- HHSN268201100001C/WH/WHI NIH HHS/United States
- 10124/CRUK_/Cancer Research UK/United Kingdom
- 16561/CRUK_/Cancer Research UK/United Kingdom
- U19 CA148107/CA/NCI NIH HHS/United States
LinkOut - more resources
Other Literature Sources